Proteus endometritis is an uncommon but clinically significant form of endometrial infection, primarily caused by Proteus mirabilis, a gram-negative facultative anaerobe. Typically associated with polymicrobial pelvic infections, this condition arises from ascending bacterial invasion of the uterine lining and often coexists with pelvic inflammatory disease (PID), postpartum infections, or post-instrumentation sepsis. Accurate diagnosis and targeted therapy are essential to prevent chronic reproductive sequelae, including infertility.

Etiology and Pathogenesis of Proteus Endometritis
The endometrium, while normally protected by cervical mucus and local immunity, can become susceptible to infection under specific circumstances such as childbirth, miscarriage, or invasive gynecological procedures.
Microbiological Profile
- Primary pathogen: Proteus mirabilis
- Virulence traits:
- Urease production, promoting an alkaline pH
- Swarming motility enabling tissue colonization
- Biofilm formation on intrauterine devices or necrotic tissue
These properties facilitate sustained infection and evasion of host immune responses, leading to localized inflammation and systemic symptoms.
Risk Factors Contributing to Proteus Endometritis
Certain medical and behavioral factors enhance vulnerability to endometrial infections caused by Proteus species:
- Postpartum or post-abortion status
- Recent uterine instrumentation (e.g., dilation and curettage, hysteroscopy)
- Intrauterine device (IUD) use
- Pelvic inflammatory disease history
- Immunosuppression
- Prolonged rupture of membranes during labor
- Diabetes mellitus
Recognition of these risk factors is critical for early intervention and prevention.
Clinical Presentation and Symptoms
Proteus endometritis may present acutely or subacutely, depending on the degree of microbial invasion and host response.
Common Signs and Symptoms
- Lower abdominal or pelvic pain
- Abnormal uterine bleeding (especially postcoital or intermenstrual)
- Foul-smelling or purulent vaginal discharge
- Fever and systemic signs of infection
- Uterine tenderness on bimanual examination
- Leukocytosis and elevated C-reactive protein (CRP)
In severe cases, the infection may ascend, leading to salpingitis or tubo-ovarian abscess.
Diagnostic Approach and Laboratory Evaluation
Prompt diagnosis hinges on a combination of clinical suspicion and laboratory findings.
Culture and Sensitivity
- Isolate Proteus mirabilis or related species from endometrial or cervical swabs
- Assess for polymicrobial flora
Imaging Indications
- Rule out retained products of conception
- Evaluate for abscesses or fluid collections in complex presentations
Antimicrobial and Supportive Treatment Protocols
Early initiation of empirical antibiotic therapy is crucial. Once microbial identification is confirmed, therapy should be adjusted accordingly.
First-Line Antibiotic Options
- Ceftriaxone + Doxycycline + Metronidazole (empirical broad-spectrum coverage)
- Amoxicillin-clavulanate in mild cases
- Fluoroquinolones as alternatives for oral step-down therapy
Antibiotic Considerations
- Avoid nitrofurantoin and tetracyclines as monotherapy for Proteus
- Duration: 10–14 days based on severity and response
Adjunctive Measures
- Removal of IUD if in place
- Surgical evacuation if retained products are identified
- Analgesics and antipyretics for symptom control
Chronic and Recurrent Proteus Endometritis
Persistent infections necessitate re-evaluation of the underlying cause, such as anatomical abnormalities, foreign bodies, or biofilm-associated resistance.
Management Strategies
- Repeated endometrial sampling to exclude resistant organisms
- Imaging to detect chronic pelvic pathology
- Long-term suppressive antibiotics in refractory cases
- Consultation with infectious disease and gynecology specialists
Complications and Prognosis
Untreated or inadequately managed Proteus endometritis may result in severe gynecological and systemic consequences.
Possible Complications
- Infertility due to scarring or tubal damage
- Chronic pelvic pain
- Pyometra (accumulation of pus in the uterus)
- Sepsis and hospitalization
- Ectopic pregnancy risk due to fallopian tube compromise
Preventive Measures and Patient Education
Preventing Proteus endometritis revolves around reducing exposure to predisposing factors and maintaining genital tract hygiene.
Key Preventive Actions
- Aseptic technique during obstetric and gynecological procedures
- Timely treatment of lower genital tract infections
- Proper IUD insertion and removal protocols
- Education on postpartum warning signs
Proteus endometritis, though less common than other uterine infections, poses significant risks to reproductive and systemic health when not identified and managed promptly. Its association with medical instrumentation, biofilm formation, and resistance patterns necessitates a vigilant, multifaceted approach to diagnosis and treatment. Through targeted antibiotic regimens, risk mitigation, and consistent follow-up, clinicians can ensure favorable outcomes and protect long-term reproductive function in affected individuals.